Two of our long time scientific advisors have been elected to the prestigious National Academy of Sciences, one of the highest honors bestowed upon research scientists.

Nathaniel Heintz, PhD
Nathaniel (Nat) Heintz is the James and Marilyn Simons Professor and head of the Laboratory of Molecular Biology at The Rockefeller University in New York. Dr. Heintz is also a Howard Hughes Medical Institute investigator. His interest and expertise lie in the development and functioning of the mammalian cerebellum.

Michael Kastan, MD, PhD
Michael (Mike) Kastan is Executive Director of the Duke Cancer Institute and the William and Jane Shingleton Professor of Pharmacology and Cancer Biology and Professor of Pediatrics at Duke University School of Medicine in North Carolina. Dr. Kastan’s laboratory has been, and continues to be, interested in how cells respond to DNA damage and other types of stress. Besides providing advice to us, Dr. Kastan’s teams over the years have made critical discoveries about the A-T protein.

Both Dr. Heintz and Dr. Kastan have served as trusted scientific advisors and friends to the A-TCP for many years, and we congratulate them both.

Oops! We could not locate your form.

Related News

Jan 23 @ 8:42 am

Press Release from Business Wire about A-T Trial Results

IntraBio announces positive trial results of Levacetylleucine for the treatment of ataxia-telangiectasia.

more
Jan 23 @ 8:42 am

Encouraging News from an A-T Clinical Trial

IntraBio announced positive results from its pivotal Phase III clinical trial of a drug for children and adults

more
Jan 23 @ 8:42 am

Heading into 2026 with big momentum for A-T

The A-TCP is excited about how much possibility this moment holds for A-T research.

more
Jan 23 @ 8:42 am

Breaking News about A-T and GRP94

A-TCP funds a researcher who sheds new light on A-T and on how the ATM gene functions in

more